Evidence map›Paper›PMID 40867321›Full record

ArticleCancers2025

Spontaneous Mesotheliomas in Germline

Yuwaraj Kadariya, Li Zhang, Eleonora Sementino, Eric Ross, Joseph R Testa

Abstract read
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yuwaraj KadariyaCancer Prevention and Control Program, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
Li ZhangBiostatistics and Bioinformatics Facility, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
Eleonora SementinoCancer Prevention and Control Program, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
Eric RossBiostatistics and Bioinformatics Facility, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
Joseph R TestaCancer Prevention and Control Program, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.ORCID 0000-0003-1301-5175

Funding

WORD PROCESSING CENTER--COREP30CA006927 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI Eric Andrew Ross · 1985 to 2026
$138.8M
Environmental Science Project 3 - Social Determinants of Risk and Attitudes AboutP42ES023720 · NIEHS · UNIVERSITY OF PENNSYLVANIA · PI BLAIR, IAN ALEXANDER · 2014 to 2018
$11.3M
PATHOLOGY, VIROLOGY, AND ANIMAL COREP01CA114047 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI CARBONE, MICHELE · 2006 to 2010
$8.0M
Pathogenesis of Malignant Mesothelioma by the Human Polycomb Complex BAP1-ASXLR01CA175691 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI RAUSCHER III, FRANK JOSEPH, TESTA, JOSEPH R. · 2014 to 2018
$2.7M
Commonwealth of Pennsylvania noneMesothelioma Applied Research Foundation noneNCI NIH HHS P01 CA114047NCI NIH HHS P30 CA006927NCI NIH HHS R01 CA175691NIEHS NIH HHS P42 ES023720NIH, National Cancer Institute CA-175691NIH, NCI CA-006927Pennsylvania DOH CURE none
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BAP1 geneBAP1 tumor predisposition syndromecancer predispositionmesotheliomamouse tumor models

Identifiers

PMID40867321
PMCPMC12384363

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.